Singapore. Germany-based specialty chemicals company Evonik today opened its first research hub for resource efficiency topics in Singapore, internationalizing its research into the areas of functional surfaces and additive manufacturing. Furthermore the new R&D hub will be the home for Evonik’s project house tissue engineering, which is under the leadership of Creavis, the strategic innovation unit of Evonik. Overall the new hub in Singapore showcases Evonik’s strategic decision to expand the internationalization of its research and development activities.
“Innovation is an integral part of our growth strategy,” said Harald Schwager, Deputy Chairman of the Board for Evonik Industries during the opening ceremony. “We are actively pursuing new opportunities to boost our international R&D activities and the opening of this research hub is a significant contribution to these efforts. By focusing on promising research areas for the future this hub will strengthen our position as a global leader in specialty chemicals.”
For Evonik, Singapore combines the best of two worlds: highly qualified researchers from leading science faculties and quick reaction times of local administration. “This research hub is ideally located to drive innovation for our Resource Efficiency segment by developing forward-looking solutions and technologies for our clients in all global markets”, added Claus Rettig, Chairman of the Board of Management, Evonik Resource Efficiency GmbH. He said: “With this new hub, we are taking advantage of a new approach to research: Enabling a creative environment for innovations and encouraging agile, flexible working.”
Located in Biopolis, the home for international and groundbreaking research in Singapore, the hub offers national and international professionals and graduates – spanning from engineers to scientists – a creative environment for innovative ideas in a highly interactive workplace. Talent from all over the world will be brought together to carry out pioneering R&D by integrating scientific and technological capabilities in a collaborative lab concept.
With the research hub, Evonik is expanding its collaboration with public and private research institutions and organizations. Evonik has formed a partnership with Nanyang Technological University, Singapore to develop novel technologies in additive manufacturing for industrial application.
“Evonik has been present in Singapore for more than 20 years and our strong regional footprint has positioned us as a market leader in the speciality chemical industry, particularly in Asia,” said Peter Meinshausen, President of Evonik Asia Pacific South. “The research hub will not only reinforce our competitive position, but will also play a critical role in pioneering impactful innovations to address industry needs and challenges in and beyond this region in the years ahead.
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-orientated innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world with more than 36,000 employees. In fiscal 2017, the enterprise generated sales of €14.4 billion and an operating profit (adjusted EBITDA) of €2.36 billion.
Evonik’s international activities are organized into six regions. The Asia Pacific North region is headquartered in Shanghai. Sales in Asia Pacific North reached 2,158 million euros in 2017. Evonik regards China as one of the driving forces of the global economy and we consequently endeavor to grow our business here. The company now employs about 3,000 employees and has in total of 10 production sites in China.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.